| Log in

Aurobindo Pharma to up stake in vaccine maker Tergene Biotech

10 August, 2017

Drugmaker Aurobindo Pharma Ltd on Thursday said it will increase its stake in vaccine developer Tergene Biotech Pvt. Ltd from 60% to 80% by subscribing to fresh shares in the company.

Aurobindo Pharma will invest Rs 5.65 crore in Tergene to subscribe to 56,50,000 equity shares of Rs 10 each, it said in a stock-exchange disclosure. The investment will be made over a period of time as per Tergene’s requirements.

Tergene Biotech is a joint venture between Aurobindo Pharma and the promoters of Tergene. Aurobindo acquired a 60% stake in the company in 2015.

Hyderabad-based Tergene is yet to commence its commercial operations.

Aurobindo Pharma is a leading pharmaceutical company producing oral and injectable generic formulations and active pharmaceutical ingredients. It has 14 manufacturing units and two research and development facilities in India. The US and Europe contribute about 84% of its total formulations revenue.

In 2016-17, Aurobindo Pharma’s consolidated net profit was Rs 2,301.20 crore on a total income of Rs 15,205.75 crore.

Like this report? Sign up for our daily newsletter to get our top reports.


Leave Your Comment
Aurobindo Pharma to buy Hyacinths Pharma, remaining stake in Silicon Life Sciences

Aurobindo Pharma to buy Hyacinths Pharma, remaining stake in Silicon Life Sciences

Lohit Jagwani 4 years ago
Aurobindo Pharma Ltd is acquiring Andhra Pradesh-based manufacturer of active...
Aurobindo Pharma sells Australian arm to Eris Pharma

Aurobindo Pharma sells Australian arm to Eris Pharma

Bhawna Gupta 3 years ago
Aurobindo Pharma Ltd, a Hyderabad-based drugmaker, has sold its entire stake in...
Aurobindo Pharma to acquire majority stake in Celon Lab’s plant & Silicon Life Sciences

Aurobindo Pharma to acquire majority stake in Celon Lab’s plant & Silicon Life Sciences

Lohit Jagwani 4 years ago
Indian pharma company Aurobindo Pharma Ltd has struck a deal to acquire majority...
No Comments

Aurobindo Pharma to up stake in vaccine maker Tergene Biotech

Powered by WordPress.com VIP